Intellia Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 65 U.S.-traded ETFs. NTLA has around 12.9M shares in the U.S. ETF market. The largest ETF holder of NTLA is the ARK Innovation ETF (ARKK), with approximately 5.09M shares. Investors may also find of interest that the ETF with the largest allocation to NTLA stock is Franklin Genomic Advancements ETF (HELX), with a portfolio weight of 5.88%. On average, U.S. ETFs allocate 0.52% of NTLA to their portfolios.
Additionally, NTLA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NTLA as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.